First one, on TLR9 regulation by Unc93b1. Triple-alanine scanning mutagenesis library revealed mutant of Unc93b1 (SKN) that abolishes TLR9 signaling, although leaves endosomal trafficking and maturation intact. Single serine mutant (S282A) is responsible for full SKN phenotype
SKN or S282A both reduce amount of TLR9 binding to CpG. Both also increase amount of TLR9 bound by Unc93b1. Other mutations in same region of Unc93b1 (loop 5) either enhance or block Unc93b1 binding but all impair TLR9 activation, with much less effect on TLR7
Replacement of juxtamembrane region of TLR9 with corresponding TLR3 sequence rescued loss of signaling in Unc93b1 S282A - suggesting juxtamembrane region binds to Unc93b1 loop 5, and altering this binding (too much or too little) blocks TLR9 signaling
Working model is TLR9 is released by Unc93b1 in endosomes to allow activation. Supporting this, there is more Unc93b1-TLR9 association in ER than endosomes, suggesting release through maturation. S282A increased association in all compartments - increased affinity for TLR9
Myd88 IP (for active signaling TLR9) failed to pull down Unc93b1, suggesting it has been released completely prior to signaling. Cysteine cross-linking through juxtamembrane mutations forced TLR9-Unc93b1 association and blocked TLR9 activation
Importantly, all these discovered mechanisms of regulation are TLR9-specific. TLR7 shows minimal to no effects with any of these Unc93b1 mutations, and does not dissociate from Unc93b1 (leading to second paper, which I’ll get to…)
Questions: What drives dissociation of Unc93b1 from TLR9 in endoscopes? Does another co-receptor displace Unc93b1, or is it membrane environment / pH driven? What does the biochemistry of the association look like, vs TLR7 that does not dissociate?
Moving on to next paper, on negative regulation of TLR7 by Syntenin-1. Same triple-alanine library on Unc93b1 reveals a C-terminal region regulating TLR7 (but not TLR3 or 9). Faster and more intense activation of downstream signaling in Unc93b1 mutant
Mutant Unc93b1 (“PKP”) does not alter TLR7 export / maturation (cleavage to active form) or localization to endosomes. Mass-spec on PKP (pull-down from phagosomes, again) identified Syntenin-1 as interacting partner of WT Unc93b1, but not PKP
Syntenin-1 is recruited specifically following TLR7, but not TLR9, stimulation. Recruitment depends on both serine phosphorylation of Unc93b1 as well as the PKP motif. Some (very rare) human SNPs in this C-terminal region of Unc93b1 result in enhanced TLR7 responses
Last, they generate PKP-knockin mice. PKP/PKP mice develop severe systemic inflammation in a TLR7-dependent manner - ANAs, hyperactivated T cells, failure to thrive, DCs and macrophages are hyper responsive to TLR7 stim. Hets have some milder phenotypes
Obvious first questions (some posed by authors) - what’s the kinase phosphorylating Unc93b1? Is there a corresponding phosphatase? How does Syntenin-1 regulate (block) Myddosome assembly? What drives Syntenin-1 dissociation?
Big question: there is some basal phosphorylation of Unc93b1 and association with Syntenin-1 even without TLR7. Does TLR7 stim result in increased phosphorylation? Or is there another mechanism enhancing Syntenin-1 recruitment (loss of another phospho-binding protein?)
Overall, two fantastic stories from @MajerOlivia and the @barton_lab! So much interesting cell biology and biochemistry of transmembrane receptor association, and I’m sure there’s even more complexity to unravel with TLR control by chaperones (Unc93b1 and more!)
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Here’s a thread on anti-interferon autoantibodies, viral infections, and human immunology. This is less a covid thread, and more an anti-covid thread, if anything…
Summary: anti-IFN auto-Abs may be reflective of chronic inflammation, and may pre-exist in vulnerable groups at high levels. Presence in severe covid cases may therefore reflect basal immune variation which impacts covid, rather than a special covid-specific phenomenon.
This is prompted based on the new Science paper on autoantibodies against Type I IFNs in severe covid patients (science.sciencemag.org/content/early/…). Basically, ~10% of severe covid patients had high titer anti-IFNa antibodies that were functionally neutralizing.
I'm grateful that others have put together resources like bit.ly/ANTIRACISMRESO…, which has helped me learn to be better. So You Want To Talk About Race by @IjeomaOluo and How To Be An Antiracist by @DrIbram have been amazing, and I'm looking forward to reading deeper.
I haven't seen a similar central resource for donations, but various recommendations led me to eji.org (Equal Justice initiative, focused on criminal justice reform and education), voterparticipation.org (get people registered to vote)...
The original paper, which was mainly based on the temperature-dependent fluorescence of a mitochondria-targeting probe, was accompanied by a “Primer” (journals.plos.org/plosbiology/ar…) highlighting potential flaws and implications, a special sort-of-peer-review step by PLOS Biology.
This new awesome resource @naturemethods - nature.com/articles/s4159… - offers some intriguing orthogonal validation. This is a proteome-wide study of protein thermal stability across 13 organisms, conducted using a mass-spec-based approach.
Super neat story on how cellular quality control impacts the mutational landscape of proteins - beneficial mutations in DHFR during deep mutational scanning are totally altered dependent on cellular QC #Biophysics#Evolutionbiorxiv.org/content/10.110… Way to go! @KortemmeLab
In an initial DMS experiment on DHFR, there were a large number (25% of all sequences!) of advantageous mutations spread across the whole protein. Reintroduction of QC protein Lon reduced the number of advantageous mutants and lowered average benefit of those mutations
Changes in selection coefficient (the “advantageous-ness”) were most striking at hydrophobic/aromatic residues and buried residues - and these correlate with Tm changes of variants. So Lon seems to be imposing higher standards on DHFR, particularly for destabilizing core mutants
A couple interesting bits of preliminary data on Langerhans cells and the huLangerin mouse used to study them. Effects of developmental absence of LCs on keratinocytes and T cells, and huLangerin-YFP labels some neurons (check your Cre mice!) #Genetics#Immunology
First - effect of loss of LCs in the huLangerin-DTA mice - biorxiv.org/content/10.110…. Bulk RNA-seq showed changes in keratinocytes and dendritic epidermal T cells, including cell-type specific changes (e.g. loss of IL17 pathway in DETCs).
Unfortunately, underlying data (either gene expression tables or raw RNA-seq data) don’t currently seem available, but hopefully the authors get that up shortly. Will be interesting to look at and prompt some hypotheses about how LCs control homeostasis and development.
CYTOF analysis of human neutrophils - 7 populations with differing phagocytosis, ROS, and FACS-compatible surface marker phenotypes. Changes in distribution between healthy + melanoma patients. #Immunology#Cancer#Neutrophilsbiorxiv.org/content/10.110…
Circulating neutrophil precursors, aged neutrophils, and a few populations of mature and immature neutrophils. Melanoma stage correlates with loss of dominant N2 (mature, ROS++, lowly phagocytic), and increase of N5 (immature, non-proliferative, ROS+, lowly phagocytic).
Interesting to note the phagocytosis-SSC staining in Fig4A - big changes in SSC for some populations with zymosan, others not so much - degranulation, different phagosomes…? Similarly, bimodal peaks for ROS production in same populations…